Morse Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.2M | Buy |
4,470
+1,345
| +43% | +$730K | 0.46% | 57 |
|
|
2025
Q4 | $1.81M | Buy |
3,125
+251
| +9% | +$142K | 0.36% | 65 |
|
|
2025
Q3 | $1.39M | Buy |
2,874
+516
| +22% | +$240K | 0.28% | 83 |
|
|
2025
Q2 | $956K | Sell |
2,358
-300
| -11% | -$125K | 0.21% | 94 |
|
|
2025
Q1 | $1.32M | Sell |
2,658
-129
| -5% | -$69.9K | 0.33% | 66 |
|
|
2024
Q4 | $1.45M | Sell |
2,787
-9,039
| -76% | -$4.97M | 0.33% | 69 |
|
|
2024
Q3 | $7.32M | Sell |
11,826
-172
| -1% | -$102K | 1.58% | 17 |
|
|
2024
Q2 | $6.63M | Sell |
11,998
-1,114
| -8% | -$638K | 1.61% | 18 |
|
|
2024
Q1 | $7.62M | Buy |
13,112
+259
| +2% | +$145K | 1.94% | 12 |
|
|
2023
Q4 | $6.82M | Sell |
12,853
-474
| -4% | -$229K | 2.01% | 14 |
|
|
2023
Q3 | $6.75M | Buy |
13,327
+166
| +1% | +$88.5K | 2.13% | 12 |
|
|
2023
Q2 | $6.87M | Buy |
13,161
+557
| +4% | +$301K | 2.09% | 11 |
|
|
2023
Q1 | $7.26M | Buy |
12,604
+113
| +0.9% | +$63.7K | 2.45% | 7 |
|
|
2022
Q4 | $6.88M | Sell |
12,491
-81
| -0.6% | -$42.9K | 2.5% | 9 |
|
|
2022
Q3 | $6.38M | Sell |
12,572
-603
| -5% | -$337K | 2.41% | 9 |
|
|
2022
Q2 | $7.16M | Buy |
13,175
+339
| +3% | +$187K | 2.3% | 8 |
|
|
2022
Q1 | $7.58M | Sell |
12,836
-5,097
| -28% | -$2.93M | 1.88% | 10 |
|
|
2021
Q4 | $12M | Buy |
17,933
+21
| +0.1% | +$13.1K | 2.67% | 6 |
|
|
2021
Q3 | $10.2M | Buy |
17,912
+306
| +2% | +$168K | 2.44% | 9 |
|
|
2021
Q2 | $8.88M | Sell |
17,606
-716
| -4% | -$338K | 2.15% | 10 |
|
|
2021
Q1 | $8.36M | Buy |
18,322
+728
| +4% | +$347K | 2.15% | 10 |
|
|
2020
Q4 | $8.2M | Sell |
17,594
-473
| -3% | -$222K | 2.27% | 12 |
|
|
2020
Q3 | $7.98M | Sell |
18,067
-850
| -4% | -$351K | 2.56% | 10 |
|
|
2020
Q2 | $6.85M | Buy |
18,917
+1,905
| +11% | +$639K | 2.44% | 11 |
|
|
2020
Q1 | $4.83M | Buy |
17,012
+622
| +4% | +$196K | 2.3% | 14 |
|
|
2019
Q4 | $5.33M | Buy |
16,390
+365
| +2% | +$111K | 1.83% | 14 |
|
|
2019
Q3 | $4.67M | Sell |
16,025
-2,725
| -15% | -$780K | 1.74% | 16 |
|
|
2019
Q2 | $5.51M | Sell |
18,750
-379
| -2% | -$104K | 1.62% | 19 |
|
|
2019
Q1 | $5.24M | Buy |
19,129
+3,650
| +24% | +$908K | 1.57% | 18 |
|
|
2018
Q4 | $3.46M | Buy |
15,479
+2,905
| +23% | +$682K | 1.23% | 26 |
|
|
2018
Q3 | $3.07M | Buy |
12,574
+7,830
| +165% | +$1.8M | 0.81% | 39 |
|
|
2018
Q2 | $983K | Buy |
4,744
+3,455
| +268% | +$733K | 0.27% | 84 |
|
|
2018
Q1 | $266K | Buy |
1,289
+75
| +6% | +$15.7K | 0.07% | 130 |
|
|
2017
Q4 | $231K | Buy |
1,214
+120
| +11% | +$23K | 0.06% | 125 |
|
|
2017
Q3 | $207K | Buy |
+1,094
| New | +$198K | 0.06% | 124 |
|
Other funds holding TMO
VCM
Morse Asset Management's TMO Position: Q1 2026 in Review
Morse Asset Management increased its Thermo Fisher Scientific (TMO) stake by 43% in Q1 2026, buying an estimated $730K and bringing the position to 4,470 shares worth $2.2M. The position accounts for 0.46% of the portfolio, ranked #57.
Morse Asset Management first reported a position in TMO in Q3 2017 and has held it in 35 quarters since. The position peaked at $12M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Morse Asset Management held 4,470 shares of Thermo Fisher Scientific worth $2.2M as of Q1 2026.
- Morse Asset Management bought 1,345 Thermo Fisher Scientific shares in Q1 2026, an estimated $730K.
- Thermo Fisher Scientific made up 0.46% of Morse Asset Management's portfolio in Q1 2026, its #57 holding.
- Morse Asset Management first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 35 quarters since.
- Morse Asset Management's Thermo Fisher Scientific position peaked at $12M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Morse Asset Management's 13F filing for Q1 2026, filed 14 May 2026.